secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001213900-24-082809
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius extends employment agreement with EVP Holubiak and insider warrants to 2025
--------------------------------------------------------------------------------

- Myron Holubiak's employment term extended by one year to Oct 31, 2025; all other terms unchanged.
- Investor warrants for 2,793,297 shares at $0.77 held by CEO Mazur and EVP Holubiak extended to Sept 27, 2025.
- Underwriter warrants for 194,358 shares at $1.11875 extended to same date, held by Wainwright representatives.
- Full exercise of all extended warrants would yield ~$2.4M in cash proceeds to the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024082809/0001213900-24-082809-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024082809/ea0215927-8k_citiuspharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-082809

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer